Covered recipient · General Payments record
ARLENE BARRETT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$2,520.79
- Reported across 38 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,305.51 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $367.13 | 3 |
| LivaNova USA, Inc. | $191.48 | 5 |
| UCB, Inc. | $125.97 | 3 |
| Amneal Pharmaceuticals LLC | $125.00 | 1 |
| EISAI INC. | $124.46 | 1 |
| Acerta Pharma LLC | $124.46 | 1 |
| Otsuka America Pharmaceutical, Inc. | $124.46 | 1 |
| Lilly USA, LLC | $122.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals LLC | $125.00 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220554914 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.46 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207015868 | CMS |
| E.R. Squibb & Sons, L.L.C. | $120.12 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184567343 | CMS |
| E.R. Squibb & Sons, L.L.C. | $124.46 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184567375 | CMS |
| E.R. Squibb & Sons, L.L.C. | $122.55 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184567411 | CMS |
| Eisai Inc. | $124.46 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244524801 | CMS |
| Lilly USA, LLC | $122.55 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187007962 | CMS |
| LivaNova USA, Inc. | $2.98 | 02/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1245684493 | CMS |
| LivaNova USA, Inc. | $6.87 | 02/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1245684498 | CMS |
| LivaNova USA, Inc. | $11.90 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1245684650 | CMS |
| LivaNova USA, Inc. | $127.00 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1245684674 | CMS |
| LivaNova USA, Inc. | $42.73 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1245684807 | CMS |
| Otsuka America Pharmaceutical, Inc. | $124.46 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227579825 | CMS |
| UCB, Inc. | $25.00 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224670284 | CMS |
| UCB, Inc. | $73.72 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224670288 | CMS |
| UCB, Inc. | $27.25 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224670292 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.